Cidel Asset Management’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Cidel Asset Management’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$21.9K	–	153
2023 Q2	$21.9K	Hold	20,000	–	–	﹤0.01%	148
2023 Q1	$13.7K	Hold	20,000	–	–	﹤0.01%	150
2022 Q4	$17.6K	Hold	20,000	–	–	﹤0.01%	154
2022 Q3	$29K	Hold	20,000	–	–	﹤0.01%	136
2022 Q2	$81K	Hold	20,000	–	–	﹤0.01%	141
2022 Q1	$132K	Hold	20,000	–	–	﹤0.01%	148
2021 Q4	$242K	Hold	20,000	–	–	0.01%	142
2021 Q3	$455K	Buy	+20,000	New	+$503K	0.02%	101

Cidel Asset Management's REUN Position: Q3 2023 in Review

Cidel Asset Management sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2023, closing a stake of 20,000 shares — an estimated $21.9K sold.

Cidel Asset Management first reported a position in REUN in Q3 2021 and held it in 8 quarters. The position peaked at $455K in Q3 2021. 0 funds tracked by Wall St. Rank hold REUN as of Q3 2023.

Cidel Asset Management reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
Cidel Asset Management sold 20,000 Reunion Neuroscience Inc. Common Shares shares in Q3 2023, an estimated $21.9K.
Cidel Asset Management first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 8 quarters.
Cidel Asset Management's Reunion Neuroscience Inc. Common Shares position peaked at $455K in Q3 2021.
0 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2023.

Based on Cidel Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.